In both cancer and inflammation processes, CX3CL1 has been shown to stimulate chemotaxis, recruiting cells that expressed CX3CR1, such as natural killer (NK) cells, dendritic cells (DCs), and monocytes [16,17,18]. The gene discussed is CX3CL1; the disease is cancer.